Pfizer (PFE) Receives EC Approval for Expanded Prevenar 13 Indication
Go back to Pfizer (PFE) Receives EC Approval for Expanded Prevenar 13 IndicationPfizer Inc. (NYSE: PFE) | Delayed: 26.27 -0.05 (0.19%) | |||||
---|---|---|---|---|---|---|
Previous Close | $26.32 | 52 Week High | $37.39 | |||
Open | $26.25 | 52 Week Low | $28.25 | |||
Day High | $26.34 | P/E | 15.92 | |||
Day Low | $26.04 | EPS | $1.65 | |||
Volume | 24,544,063 |